These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
906 related articles for article (PubMed ID: 30527243)
1. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243 [TBL] [Abstract][Full Text] [Related]
2. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy. Driehuis E; Kolders S; Spelier S; Lõhmussaar K; Willems SM; Devriese LA; de Bree R; de Ruiter EJ; Korving J; Begthel H; van Es JH; Geurts V; He GW; van Jaarsveld RH; Oka R; Muraro MJ; Vivié J; Zandvliet MMJM; Hendrickx APA; Iakobachvili N; Sridevi P; Kranenburg O; van Boxtel R; Kops GJPL; Tuveson DA; Peters PJ; van Oudenaarden A; Clevers H Cancer Discov; 2019 Jul; 9(7):852-871. PubMed ID: 31053628 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity. Lee J; You JH; Shin D; Roh JL J Cancer Res Clin Oncol; 2020 Oct; 146(10):2497-2507. PubMed ID: 32620987 [TBL] [Abstract][Full Text] [Related]
4. Differential Angiogenic Potential of 3-Dimension Spheroid of HNSCC Cells in Mouse Xenograft. Choi SY; Kang SH; Oh SY; Lee KY; Lee HJ; Gum S; Kwon TG; Kim JW; Lee ST; Hong YJ; Kim DG; Hong SH Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361027 [TBL] [Abstract][Full Text] [Related]
5. High-throughput screening in colorectal cancer tissue-originated spheroids. Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380 [TBL] [Abstract][Full Text] [Related]
7. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads. Kochanek SJ; Close DA; Johnston PA Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624 [TBL] [Abstract][Full Text] [Related]
8. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer. Xie BY; Wu AW Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics. Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids. de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck. Henriksson E; Kjellén E; Baldetorp B; Bendahl PO; Borg A; Brun E; Mertens F; Ohlsson T; Rennstam K; Wennerberg J; Wahlberg P J Exp Clin Cancer Res; 2009 Feb; 28(1):17. PubMed ID: 19216775 [TBL] [Abstract][Full Text] [Related]
12. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells. Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598 [TBL] [Abstract][Full Text] [Related]
13. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors. Maru Y; Tanaka N; Itami M; Hippo Y Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504 [TBL] [Abstract][Full Text] [Related]
14. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma. Ryumon S; Okui T; Kunisada Y; Kishimoto K; Shimo T; Hasegawa K; Ibaragi S; Akiyama K; Thu Ha NT; Monsur Hassan NM; Sasaki A Oncol Rep; 2019 Dec; 42(6):2611-2621. PubMed ID: 31638244 [TBL] [Abstract][Full Text] [Related]
15. CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab. Niehr F; Weichert W; Stenzinger A; Budach V; Tinhofer I J Transl Med; 2015 Apr; 13():106. PubMed ID: 25890004 [TBL] [Abstract][Full Text] [Related]
16. The establishment of kidney cancer organoid line in drug testing. Tse RT; Wong CY; Ding X; Cheng CK; Chow C; Chan RC; Ng JH; Tang VW; Chiu PK; Teoh JY; Wong N; To KF; Ng CF Cancer Med; 2024 Jun; 13(12):e7432. PubMed ID: 38923304 [TBL] [Abstract][Full Text] [Related]
17. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer. Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147 [TBL] [Abstract][Full Text] [Related]
18. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms. Lindemann A; Patel AA; Silver NL; Tang L; Liu Z; Wang L; Tanaka N; Rao X; Takahashi H; Maduka NK; Zhao M; Chen TC; Liu W; Gao M; Wang J; Frank SJ; Hittelman WN; Mills GB; Myers JN; Osman AA Clin Cancer Res; 2019 Sep; 25(18):5650-5662. PubMed ID: 31308060 [TBL] [Abstract][Full Text] [Related]
20. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy. Kondo J; Inoue M Cells; 2019 May; 8(5):. PubMed ID: 31108870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]